SOGA1: A Potential Drug Target and Biomarker for Glucose and Autophagy

Target Name: SOGA1

NCBI ID: G140710

SOGA1

SOGA1: A Potential Drug Target and Biomarker for Glucose and Autophagy

Sugar metabolism is a critical regulator of human health and disease, with high levels of blood sugar leading to a range of health problems, including diabetes, obesity, and cardiovascular disease. The study of sugar metabolism has also identified a protein called SOGA1 as a potential drug target and biomarker for glucose and autophagy.

SOGA1 stands for suppressor of glucose, autophagy-associated protein 1. It is a protein that is expressed in all human tissues and is involved in the regulation of glucose metabolism. SOGA1 plays a critical role in the negative feedback loop that regulates glucose levels in the body. When glucose levels rise, SOGA1 helps to lower them, and when glucose levels fall, it helps to raise them.

SOGA1 is also involved in the regulation of autophagy, a process by which cells break down and recycle their own damaged or unnecessary components. SOGA1 has been shown to play a role in the regulation of autophagy in various cell types, including cancer cells.

SOGA1 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of cancer. For example, studies have shown that SOGA1 is often overexpressed in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that SOGA1 may be a useful biomarker for the diagnosis and treatment of these cancers.

In addition to its role in sugar metabolism and autophagy, SOGA1 has also been shown to be involved in the regulation of cellular signaling pathways that are important for the development and progression of cancer. For example, SOGA1 has been shown to be involved in the regulation of the PI3K/AKT signaling pathway, a pathway that is important for the growth and survival of cancer cells.

SOGA1 has also been shown to be involved in the regulation of the NF-kappa-B signaling pathway, a pathway that is important for the regulation of inflammation and cellular signaling. This suggests that SOGA1 may be involved in the development and progression of cancer by contributing to the regulation of cellular signaling pathways that promote inflammation and cancer growth.

In conclusion, SOGA1 is a protein that is involved in the regulation of glucose metabolism and autophagy. Its role in these processes makes it a potential drug target and biomarker for the diagnosis and treatment of various types of cancer. Further research is needed to fully understand the role of SOGA1 in sugar metabolism and autophagy, as well as its potential as a drug target and biomarker.

Protein Name: Suppressor Of Glucose, Autophagy Associated 1

Functions: Regulates autophagy by playing a role in the reduction of glucose production in an adiponectin- and insulin-dependent manner

The "SOGA1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SOGA1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets